Temperature Affects Leukocyte Surface Antigen Expression
By LabMedica International staff writers Posted on 14 Apr 2011 |
Flow cytometry analysis of leukocyte surface antigens has been used to characterize infectious and septic processes in patients.
Factors that affect leukocyte immunophenotyping include sampling and processing temperature, the anticoagulant used, and the storage temperature of the blood sample.
Scientists at the University of Oulu, (Oulu, Finland), investigated the possible effects of anticoagulant, sample collection, storage and processing temperature, and sample storage time, on the expression of several leukocyte surface antigens. They collected blood from five male patients, aged 44-68, with severe sepsis requiring intensive care and five healthy staff members (two males and three females, aged 22-62). In this study, the patients and the healthy volunteers were combined into one study population.
Blood was collected into siliconized vacuum tubes containing acid citrate dextrose (ACD) or sodium heparin as an anticoagulant and stored either at 4 °C or at room temperature (RT). Aliquots of the blood samples were incubated with various antibodies at different temperatures and times and analyzed on a FACSCalibur flow cytometer (BD Bioscience; San Jose, CA, USA). The surface antigens of interest were neutrophilic cluster of differentiation (CD)11b and CD64, monocytic CD11b, CD14, CD40, CD64, CD80 and human leukocyte antigen, HLA-DR, and lymphocytic CD69 (separately in CD4+ and CD8+ T cells, B cells, and natural killer cells).
The fluorescence intensities were higher at RT than at 4 °C. During storage the intensities increased at RT, but at 4 °C there were only minor changes. The effects were similar with both anticoagulants studied. The authors concluded that the study shows in a quantitative way that storing the blood samples at RT may have pronounced effects on the intensities of several leukocyte surface antigens, something which is of interest in leukocyte activation studies, such as patients with sepsis. They recommended that flow cytometric analysis of leukocyte surface antigen expressions should be performed using 4 °C temperature throughout the process and within six hours. The study was published online March 15, 2011, in the Journal of Clinical Laboratory Analysis.
Related Links:
University of Oulu
BD Bioscience
Factors that affect leukocyte immunophenotyping include sampling and processing temperature, the anticoagulant used, and the storage temperature of the blood sample.
Scientists at the University of Oulu, (Oulu, Finland), investigated the possible effects of anticoagulant, sample collection, storage and processing temperature, and sample storage time, on the expression of several leukocyte surface antigens. They collected blood from five male patients, aged 44-68, with severe sepsis requiring intensive care and five healthy staff members (two males and three females, aged 22-62). In this study, the patients and the healthy volunteers were combined into one study population.
Blood was collected into siliconized vacuum tubes containing acid citrate dextrose (ACD) or sodium heparin as an anticoagulant and stored either at 4 °C or at room temperature (RT). Aliquots of the blood samples were incubated with various antibodies at different temperatures and times and analyzed on a FACSCalibur flow cytometer (BD Bioscience; San Jose, CA, USA). The surface antigens of interest were neutrophilic cluster of differentiation (CD)11b and CD64, monocytic CD11b, CD14, CD40, CD64, CD80 and human leukocyte antigen, HLA-DR, and lymphocytic CD69 (separately in CD4+ and CD8+ T cells, B cells, and natural killer cells).
The fluorescence intensities were higher at RT than at 4 °C. During storage the intensities increased at RT, but at 4 °C there were only minor changes. The effects were similar with both anticoagulants studied. The authors concluded that the study shows in a quantitative way that storing the blood samples at RT may have pronounced effects on the intensities of several leukocyte surface antigens, something which is of interest in leukocyte activation studies, such as patients with sepsis. They recommended that flow cytometric analysis of leukocyte surface antigen expressions should be performed using 4 °C temperature throughout the process and within six hours. The study was published online March 15, 2011, in the Journal of Clinical Laboratory Analysis.
Related Links:
University of Oulu
BD Bioscience
Latest Immunology News
- Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
- Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
- Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions
- Cerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
- New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
- Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
- Novel Analytical Method Tracks Progression of Autoimmune Diseases
- 3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response
- Blood Test for Fungal Infections Could End Invasive Tissue Biopsies
- Cutting-Edge Microscopy Technology Enables Tailored Rheumatology Therapies
- New Discovery in Blood Immune Cells Paves Way for Parkinson's Disease Diagnostic Test
- AI Tool Uses Routine Blood Tests to Predict Immunotherapy Response for Various Cancers
- Blood Test Can Predict How Long Vaccine Immunity Will Last
- Microfluidic Chip-Based Device to Measure Viral Immunity
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Blood Biomarker Test Could Detect Genetic Predisposition to Alzheimer’s
New medications for Alzheimer’s disease, the most common form of dementia, are now becoming available. These treatments, known as “amyloid antibodies,” work by promoting the removal of small deposits from... Read more
Novel Autoantibody Against DAGLA Discovered in Cerebellitis
Autoimmune cerebellar ataxias are strongly disabling disorders characterized by an impaired ability to coordinate muscle movement. Cerebellar autoantibodies serve as useful biomarkers to support rapid... Read more
Gene-Based Blood Test Accurately Predicts Tumor Recurrence of Advanced Skin Cancer
Melanoma, an aggressive form of skin cancer, becomes extremely difficult to treat once it spreads to other parts of the body. For patients with metastatic melanoma tumors that cannot be surgically removed... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures
Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more
New Error-Corrected Method to Help Detect Cancer from Blood Samples Alone
"Liquid biopsy" technology, which relies on blood tests for early cancer detection and monitoring cancer burden in patients, has the potential to transform cancer care. However, detecting the mutational... Read more
"Metal Detector" Algorithm Hunts Down Vulnerable Tumors
Scientists have developed an algorithm capable of functioning as a "metal detector" to identify vulnerable tumors, marking a significant advancement in personalized cancer treatment. This breakthrough... Read more
Novel Technique Uses ‘Sugar’ Signatures to Identify and Classify Pancreatic Cancer Cell Subtypes
Pancreatic cancer is often asymptomatic in its early stages, making it difficult to detect until it has progressed. Consequently, only 15% of pancreatic cancers are diagnosed early enough to allow for... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more